Gastrointestinal disorders affect millions of people every year, yet the root cause often hides deep inside the stomach lining — a bacteria known as Helicobacter pylori (H. pylori). This infection is one of the world’s most common causes of gastritis, peptic ulcers, abdominal discomfort, chronic indigestion, and in severe cases, even stomach cancer (UBT ¹³C Urea Breath Analyzer).
Early detection can prevent complications, improve treatment outcomes, and restore quality of life. But until recently, diagnosing H. pylori was either invasive, uncomfortable, or inaccurate.
This is where ALOFT–UBT ¹³C Urea Breath Analyzer brings a revolution in gastrointestinal diagnostics.
Designed by Aloft MedTech, ALOFT–UBT is a non-invasive, highly accurate, fast, and safe diagnostic tool that makes H. pylori testing simple for clinicians and painless for patients. With global guidelines recognizing the ¹³C Urea Breath Test (UBT) as the gold standard for H. pylori detection, ALOFT–UBT ensures healthcare providers deliver precise clinical decisions with confidence.
Why H. pylori Diagnosis Matters More Than Ever
Millions of people worldwide silently suffer from H. pylori, often without knowing it. Left untreated, it can lead to:
- Gastritis
- Peptic or duodenal ulcers
- Chronic indigestion
- Vitamin B12 deficiency
- Iron deficiency anemia
- Gastric mucosal damage
- Increased risk of gastric cancer
Because the symptoms overlap with acidity, gastric irritation, or dietary issues, patients often ignore the signs. The key lies in early detection, and that requires a diagnostic method that is accurate, safe, fast, and non-invasive.
For years, clinicians relied on:
- Invasive endoscopies
- Stool antigen tests
- Blood IgG/serology
- Rapid urease tests
- Ammonia breath tests
But each came with limitations — either delayed results, lower accuracy, invasive procedures, or high false positives.
This clinical gap created an urgent need for a patient-friendly test with gold-standard accuracy, and ALOFT–UBT answers that need perfectly.
What Is ALOFT–UBT?
ALOFT–UBT (¹³C Urea Breath Analyzer) is a breakthrough diagnostic device developed to detect H. pylori infection using the globally accepted ¹³C Urea Breath Test (UBT) technology.
Key Purpose
To diagnose:
- H. pylori infection
- Test-of-cure after treatment
What Makes ALOFT–UBT Special?
- Non-invasive test — no endoscopy, no biopsy
- Simple protocol — no messy stool samples, no blood draw
- Safe for children and pregnant women
- Fast results — analytical readings in under 3 minutes
- High accuracy — 95–98% sensitivity and 97–100% specificity
- Complete test within 30 minutes
- OPD-friendly and lab-friendly
Designed for OPD clinics, multi-specialty hospitals, and diagnostic centers, ALOFT–UBT empowers clinicians to diagnose H. pylori with speed, confidence, and precision.
How ALOFT–UBT Works: Simple & Patient-Friendly
The test protocol is straightforward and comfortable, making it ideal for all age groups (3+ years).
Operational Procedure
Step 1:
Blow air into the first collection bag (baseline sample).
Step 2:
Drink a sachet of ¹³C urea mixed with 40–50 ml of water.
Step 3:
Wait for 30 minutes.
Step 4:
Exhale into the second collection bag (post-ingestion sample).
Step 5:
Insert both bags into the ALOFT–UBT analyzer for testing.
Within 3 minutes, the analyzer generates accurate results indicating either the presence or absence of H. pylori.
This painless, non-invasive experience significantly improves patient compliance and satisfaction.
Why ALOFT–UBT Is the Gold Standard for H. pylori Detection
1. Non-Radioactive & Completely Safe
ALOFT–UBT uses ¹³C, a stable non-radioactive isotope, making it:
- Safe even for kids
- Safe for pregnant women
- Safe for repeated follow-up tests
2. High Sensitivity & Specificity
Studies show:
- Sensitivity: 95–98%
- Specificity: 97–100%
This means the test rarely misses an infection and rarely gives false positives.
3. Globally Recommended as First-Line Test
Leading international guidelines endorse ¹³C Urea Breath Test as the preferred diagnostic tool:
| Organization | Recommendation |
|---|---|
| Maastricht VI (2022) | First-line diagnostic & follow-up tool |
| ACG Guidelines | Preferred for test-of-cure |
| WGO H. pylori Guide | Best non-invasive method available |
ALOFT–UBT ensures clinical compliance with these global standards.
4. Faster Than Most Diagnostic Methods
| Test Type | Turnaround Time | Drawbacks |
|---|---|---|
| ALOFT–UBT (¹³C UBT) | 20–30 minutes | None; gold standard |
| Stool Antigen Test | 24–48 hours | Moderate accuracy |
| Serology (IgG) | 15–30 minutes | Not for follow-up |
| Endoscopy + Biopsy | 3–5 days | Invasive |
| Rapid Urease Test | 1–2 hours | Requires endoscopy |
| Ammonia Breath Test | 30 minutes | Lower reliability |
ALOFT–UBT provides both:
✔ rapid diagnosis
✔ high reliability
5. Highly Reproducible
The device offers:
- Low variability
- Excellent repeatability
- Consistent results across batches
(6sd < 0.3%)
6. Advanced Urea Granules
ALOFT–UBT uses the latest ¹³C urea formulation, which:
- Dissolves quickly
- Provides strong metabolic reaction
- Enhances detection accuracy
- Ensures clear differentiation between positive and negative cases
Applications of ALOFT–UBT
✔ Detection of Active H. pylori Infection
Ideal for patients with:
- Gastric discomfort
- Acidic symptoms
- Indigestion
- Bloating
- Persistent abdominal pain
✔ Test of Cure
Essential to confirm eradication after antibiotic therapy.
As per global guidelines, follow-up testing must be done using:
- ¹³C Urea Breath Test, not stool antigen or serology.
ALOFT–UBT meets this requirement perfectly.
Product Highlights of ALOFT–UBT
1. Patient-Friendly Technology
- Non-invasive
- Painless
- No blood draws
- No stool samples
- No endoscopy
2. Rapid Analytical Results
- Results available in under 3 minutes once samples are inserted
3. High Clinical Accuracy
- Sensitivity: 95%+
- Specificity: 100%
4. Safe for All
- Suitable for children above 3 years
- Safe for pregnant women
- No radiation risk
5. Easy Integration
- Works effortlessly in:
- OPDs
- Diagnostic centers
- GI clinics
- Hospitals
- Medical colleges
6. Automated Testing
- 2–3 minutes per sample set
- One-touch operation
- Automated control system
Product Specifications
- Power Supply: AC100–240V, 50–60Hz
- Power Consumption: <100W
- Range of CO₂ Concentration: 0.5–6%
- Sample Volume: >120 ml
- Device Dimension: 330mm × 435mm × 236mm
- Weight: 15 kg
Why ALOFT–UBT Outperforms Ammonia Breath Tests (ABT)
Many labs still use ABT due to low cost, but it suffers from major limitations:
Problems with ABT
- Affected by liver, kidney, and oral bacteria
- High chances of false positives and negatives
- Not recommended in any GI guidelines
- Poor reliability for clinical decision-making
ALOFT–UBT advantages
- Measures exhaled ¹³CO₂ after urea metabolism — highly specific
- Endorsed by Maastricht VI, Kyoto Consensus, and ACG
- Gold-standard accuracy (95–98% sensitivity, 97–100% specificity)
- Reliable for diagnosis and follow-up
Who Should Adopt ALOFT–UBT?
1. Hospitals
Improve diagnostic accuracy and reduce invasive GI procedures.
2. Diagnostic Laboratories
Offer a gold-standard test that increases patient trust and repeat visits.
3. Gastroenterology Clinics
Enhance diagnostic workflows and clinical outcomes.
4. Corporate Healthcare Centers
Ideal for preventive health checkups and routine GI screening.
5. Teaching Hospitals & Research Centers
Accurate data for clinical studies and academic excellence.
Benefits for Patients
- Completely painless
- No discomfort or fear
- Quick 30-minute process
- Suitable for kids and pregnant women
- Highly reliable results for proper treatment
Benefits for Clinicians
- Confident diagnosis
- Globally endorsed method
- Lower false positive rate
- Better patient satisfaction
- Streamlined workflow
Why Aloft MedTech Created ALOFT–UBT
Aloft MedTech builds healthcare solutions rooted in:
✔ Empathy
Understanding real-world diagnostic challenges faced by patients and doctors.
✔ Evidence
Using clinical research, expert feedback, and standardized testing.
✔ Engineering
Developing globally relevant, robust, and reliable diagnostic systems.
ALOFT–UBT represents this philosophy — a device that merges scientific precision with patient comfort.
Conclusion: A New Era in H. pylori Diagnosis Starts with ALOFT–UBT
As gastrointestinal disorders rise globally, accurate and timely diagnosis is more important than ever. With ALOFT–UBT, clinicians get a tool that is:
- Non-invasive
- Gold-standard accurate
- Safe for all ages
- Fast and efficient
- Globally compliant
- Clinically reliable
It transforms H. pylori testing from invasive, slow, and uncomfortable…
to quick, painless, and highly accurate.
For hospitals, labs, and GI specialists looking to elevate diagnostic quality, ALOFT–UBT is the upgrade the industry has long awaited.
Frequently Asked Questions (FAQs)
1. Is ALOFT–UBT safe for children and pregnant women?
Yes. It uses a non-radioactive ¹³C isotope, making it completely safe.
2. How long does the test take?
The entire test takes about 30 minutes, with results in under 3 minutes.
3. Does the patient need to fast?
Usually, a short fasting period is recommended. Clinicians can guide case-wise.
4. Is ALOFT–UBT useful after treatment?
Yes. It is the gold-standard test-of-cure, recommended globally.
5. What makes ALOFT–UBT more accurate than stool antigen or serology tests?
It detects active bacterial metabolism, not past exposure — resulting in higher accuracy.
6. Does the device require trained technicians?
Basic training is sufficient. The device is designed for easy one-touch operation.
